Physician

Aaron Brooks, DO

According to 2025 Medicare claims, Aaron Brooks, DO (NPI: 1740775980) practices pulmonary disease in the Pensacola-Ferry Pass-Brent, FL market, with the plurality of this provider's patient population coming from Escambia, FL. This provider's primary affiliated billing organization is PENSACOLA LUNG GROUP, M.D.'S, P.A. (NPI: 1619196151; TIN: 592313481) and primary practice location at 32504-8721.

Brooks' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 233 traditional Medicare patients, billed 541 HCPCS/CPT codes, and received $57,201 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 387 prescription claims across 70 beneficiaries totaling $214,217 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 24 claims. Open Payments data shows 4 records totaling $76. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $983 to $214,217. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	20	27	$1,480
2023	40	64	$4,431
2024	233	541	$57,201

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	24	38	$983
2019	54	97	$7,957
2020	51	269	$14,047
2021	45	372	$47,882
2022	33	163	$71,200
2023	55	353	$136,085
2024	70	387	$214,217

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	24	$1,733

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	53	112	$168
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	46	46	$135
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	19	21	$99
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	97	184	$92
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	57	78	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	78	2,520	$52,731
Nucala	Mepolizumab	12	336	$46,082
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	33	1,110	$23,656
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	17	690	$10,563
Symbicort	Budesonide/Formoterol Fumarate	34	1,320	$9,963

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	24	$1,733

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$76	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaron Brooks, DO?

Tedicare shows public-source Medicare data for Aaron Brooks, DO (NPI 1740775980), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Brooks, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aaron Brooks, DO?

Aaron Brooks, DO is linked to PENSACOLA LUNG GROUP, M.D.'S, P.A. (billing NPI 1619196151) in the available physician profile data.

Does Aaron Brooks, DO have Open Payments data?

Aaron Brooks, DO has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.